Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
株式のランク
#815
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
株価
$25.47
時価総額
$30.86B
変化（1日）
3.53%
変化（1年）
-18.86%
国
CN
取引 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
カテゴリー
Healthcare
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（300760）の利益
Jun 2026 時点の利益 TTM: $1.35B
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. の最新の財務報告によると、同社の現在の利益は $1.35B です。2023 年には $1.84B の利益を上げ、これは 2022 年の利益 $1.59B と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. の利益の推移（2014 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $1.35B | -24.34% |
| 2024 | $1.78B | -2.96% |
| 2023 | $1.84B | 15.75% |
| 2022 | $1.59B | 11.93% |
| 2021 | $1.42B | 24.59% |
| 2020 | $1.14B | 47.70% |
| 2019 | $770.94M | 25.12% |
| 2018 | $616.16M | 36.76% |
| 2017 | $450.55M | 68.95% |
| 2016 | $266.68M | 58.95% |
| 2015 | $167.78M | -28.63% |
| 2014 | $235.08M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $7.51B | 456.53% |
US
|
|
| $5.56B | 312.19% |
IE
|
|
| $5.15B | 281.44% |
US
|
|
| $3.86B | 186.08% |
US
|
|
| - | - |
DE
|
